Therefore, targeting Krm1 and Dkks to inhibit Wnt pathway activation may be an effective approach for regulating CAVD, but the importance of Dkks and Krm1 in CAVD has not been reported. Here, KREMEN1 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.